World Scientific
Skip main navigation

Cookies Notification

We use cookies on this site to enhance your user experience. By continuing to browse the site, you consent to the use of our cookies. Learn More
×
Our website is made possible by displaying certain online content using javascript.
In order to view the full content, please disable your ad blocker or whitelist our website www.worldscientific.com.

System Upgrade on Mon, Jun 21st, 2021 at 1am (EDT)

During this period, the E-commerce and registration of new users may not be available for up to 6 hours.
For online purchase, please visit us again. Contact us at [email protected] for any enquiries.

Arctii Fructus Inhibits Colorectal Cancer Cell Proliferation and MMPs Mediated Invasion via AMPK

    Although Arctii Fructus (AF) has been shown to have various pharmacological effects, there have been no studies concerning the inhibitory effects of AF on the metastatic properties of colorectal cancer (CRC). The aim of this study was to investigate whether AF could suppress CRC progression by inhibiting cell growth, epithelial-mesenchymal transition (EMT), migration, and the invasion ability of CRC cells. AF decreased proliferation of CRC cells by inducing cell cycle arrest and apoptosis via extrinsic and intrinsic apoptotic pathways. Regarding metastatic properties, AF inhibited EMT by increasing the expression of the epithelial marker, E-cadherin, and decreasing the expression of the mesenchymal marker, N-cadherin, in CT26 cells. Moreover, AF decreased the migration and invasion of CT26 cells by inhibiting matrix metalloproteinase-2 (MMP-2) and MMP-9 activity. We confirmed that the decreased invasion ability and MMP-9 activity by AF treatment involved AMP-activated protein kinase (AMPK) activation. Collectively, this study demonstrates that AF inhibits the proliferation and metastatic properties of CRC cells.

    References

    • Abbas, T. and A. Dutta. p21 in cancer: Intricate networks and multiple activities. Nat. Rev. Cancer 9: 400–414, 2009. Crossref, Medline, ISIGoogle Scholar
    • Baba, Y., K. Nosho, K. Shima, J.A. Meyerhardt, A.T. Chan, J.A. Engelman, L.C. Cantley, M. Loda, E. Giovannucci, C.S. Fuchs and S. Ogino. Prognostic significance of AMP-activated protein kinase expression and modifying effect of MAPK3/1 in colorectal cancer. Br. J. Cancer 103: 1025–1033, 2010. Crossref, Medline, ISIGoogle Scholar
    • Benard, A., C.M. Janssen, P.J. van den Elsen, M.C. van Eggermond, D.S. Hoon, C.J. van de Velde and P.J. Kuppen. Chromatin status of apoptosis genes correlates with sensitivity to chemo-, immune- and radiation therapy in colorectal cancer cell lines. Apoptosis 19: 1769–1778, 2014. Crossref, Medline, ISIGoogle Scholar
    • Bronsert, P., K. Enderle-Ammour, M. Bader, S. Timme, M. Kuehs, A. Csanadi, G. Kayser, I. Kohler, D. Bausch, J. Hoeppner, U.T. Hopt, T. Keck, E. Stickeler, B. Passlick, O. Schilling, C.P. Reiss, Y. Vashist, T. Brabletz, J. Berger, J. Lotz, J. Olesch, M. Werner and U.F. Wellner. Cancer cell invasion and EMT marker expression: A three-dimensional study of the human cancer-host interface. J. Pathol. 234: 410–422, 2014. Crossref, Medline, ISIGoogle Scholar
    • Cai, W.S., F. Shen, Z. Feng, J.W. Chen, Q.C. Liu, E.M. Li, B. Xu and J. Cao. Downregulation of CDK-8 inhibits colon cancer hepatic metastasis by regulating Wnt/β-catenin pathway. Biomed. Pharmacother. 74: 153–157, 2015a. Crossref, Medline, ISIGoogle Scholar
    • Cai, Y., X. Fang, C. He, P. Li, F. Xiao, Y. Wang and M. Chen. Cucurbitacins: A systematic review of the phytochemistry and anticancer activity. Am. J. Chin. Med. 43: 1331–1350, 2015b. Link, ISIGoogle Scholar
    • Cerezo, M., M. Tichet, P. Abbe, M. Ohanna, A. Lehraiki, F. Rouaud, M. Allegra, D. Giacchero, P. Bahadoran, C. Bertolotto, S. Tartare-Deckert, R. Ballotti and S. Rocchi. Metformin blocks melanoma invasion and metastasis development in AMPK/p53-dependent manner. Mol. Cancer Ther. 12: 1605–1615, 2013. Crossref, Medline, ISIGoogle Scholar
    • Chen, G.R., H.F. Li, D.Q. Dou, Y.B. Xu, H.S. Jiang, F.R. Li and T.G. Kang. (-)-Arctigenin as a lead compound for anticancer agent. Nat. Prod. Res. 27: 2251–2255, 2013. Crossref, Medline, ISIGoogle Scholar
    • Esfahanian, N., Y. Shakiba, B. Nikbin, H. Soraya, N. Maleki-Dizaji, M. Ghazi-Khansari and A. Garjani. Effect of metformin on the proliferation, migration, and MMP-2 and -9 expression of human umbilical vein endothelial cells. Mol. Med. Rep. 5: 1068–1074, 2012. Crossref, Medline, ISIGoogle Scholar
    • Fidler, I.J. The pathogenesis of cancer metastasis: The ‘seed and soil’ hypothesis revisited. Nat. Rev. Cancer 3: 453–458, 2003. Crossref, Medline, ISIGoogle Scholar
    • Gao, X., C. Tang, W. Shi, S. Feng, W. Qin, T. Jiang and T. Sun. Semaphorin-3F functions as a tumor suppressor in colorectal cancer due to regulation by DNA methylation. Int. J. Clin. Exp. Pathol. 8: 12766–12774, 2015. Medline, ISIGoogle Scholar
    • Han, Y.H., J.Y. Kee, D.S. Kim, J. Park, M.Y. Jeong, J.G. Mun, S.J. Park, J.H. Lee, J.Y. Um and S.H. Hong. Anti-obesity effects of Arctii Fructus (Arctium lappa) in white/brown adipocytes and high-fat diet-induced obese mice. Food Funct. 7: 5025–5033, 2016a. Crossref, Medline, ISIGoogle Scholar
    • Han, Y.H., J.Y. Kee, D.S. Kim, J.G. Mun, M.Y, Jeong, S.H. Park, B.M. Choi, S.J. Park, H.J. Kim, J.Y. Um and S.H. Hong. Arctigenin inhibits lung metastasis of colorectal cancer by regulating cell viability and metastatic phenotypes. Molecules 21: E1135, 2016b. Crossref, Medline, ISIGoogle Scholar
    • Han, Y.H., J.Y. Kee, J. Park, D.S. Kim, S. Shin, D.H. Youn, J. Kang, Y. Jung, Y.M. Lee, J.H. Park, S.J. Kim, J.Y. Um and S.H. Hong. Lipin1-mediated repression of adipogenesis by rutin. Am. J. Chin. Med. 44: 565–578, 2016c. Link, ISIGoogle Scholar
    • Hirose, M., T. Yamaguchi, C. Lin, N. Kimoto, M. Futakuchi, T. Kono, S. Nishibe and T. Shirai. Effects of arctiin on PhIP-induced mammary, colon and pancreatic carcinogenesis in female Sprague-Dawley rats and MeIQx-induced hepatocarcinogenesis in male F344 rats. Cancer Lett. 155: 79–88, 2000. Crossref, Medline, ISIGoogle Scholar
    • Ito, K. and S.J. Ralph. Inhibiting galectin-1 reduces murine lung metastasis with increased CD4 (+) and CD8 (+) T cells and reduced cancer cell adherence. Clin. Exp. Metastasis 29: 561–572, 2012. Crossref, Medline, ISIGoogle Scholar
    • Jao, H.Y., F.S. Yu, C.S. Yu, S.J. Chang, K.C. Liu, C.L. Liao, B.C. Ji, D.T. Bau and J.G. Chung. Suppression of the migration and invasion is mediated by triptolide in B16F10 mouse melanoma cells through the NF-κ B-dependent pathway. Environ. Toxicol. 31: 1974–1981, 2016. Crossref, Medline, ISIGoogle Scholar
    • Kalluri, R. and R.A. Weinberg. The basics of epithelial-mesenchymal transition. J. Clin. Invest. 119: 1420–1428, 2009. Crossref, Medline, ISIGoogle Scholar
    • Kim, C.W., R.E. Go, H.M. Lee, K.A. Hwang, K. Lee, B. Kim, M.Y. Lee and K.C. Choi. Cigarette smoke extracts induced the colon cancer migration via regulating epithelial mesenchymal transition and metastatic genes in human colon cancer cells. Environ. Toxicol. 32: 690–704, 2017. Crossref, Medline, ISIGoogle Scholar
    • Kim, D.S., H.J. Lee, Y.D. Jeon, Y.H. Han, J.Y. Kee, H.J. Kim, H.J. Shin, J. Kang, B.S. Lee, S.H. Kim, S.J. Kim, S.H. Park, B.M. Choi, S.J. Park, J.Y. Um and S.H. Hong. Alpha-pinene exhibits anti-inflammatory activity through the suppression of MAPKs and the NF-κB pathway in mouse peritoneal macrophages. Am. J. Chin. Med. 43: 731–742, 2015. Link, ISIGoogle Scholar
    • Kim, H., M. Kim, E. Ju, Y. Yang, M. Lee and J. Lim. Berberine induced AMPK activation inhibits the metastatic potential of melanoma cells via reduction of ERK activity and COX-2 protein expression. Biochem. Pharmacol. 83: 385–394, 2012. Crossref, Medline, ISIGoogle Scholar
    • Kim, S.P., S.H. Nam and M. Friedman. Hericium erinaceus (Lion’s Mane) mushroom extracts inhibit metastasis of cancer cells to the lung in CT-26 colon cancer-transplanted mice. J. Agric. Food Chem. 61: 4898–4904, 2013. Crossref, Medline, ISIGoogle Scholar
    • Kwak, Y. and J. Ju. Inhibitory activities of Perilla frutescens britton leaf extract against the growth, migration, and adhesion of human cancer cells. Nutr. Res. Pract. 9: 11–16, 2015. Crossref, Medline, ISIGoogle Scholar
    • Lan, Q., S. Li, W. Lai, H. Xu, Y. Zhang, Y. Zeng, W. Lan and Z. Chu. Methyl sartortuoate inhibits colon cancer cell growth by inducing apoptosis and G2/M-phase arrest. Int. J. Mol. Sci. 16: 19401–19418, 2015. Crossref, Medline, ISIGoogle Scholar
    • Lao, X., Q. Feng, G. He, M. Ji, D. Zhu, P. Xu, W. Tang, J. Xu and X. Qin. Immature colon carcinoma transcript-1 (ICT1) expression correlates with unfavorable prognosis and survival in patients with colorectal cancer. Ann. Surg. Oncol. 23: 3924–3933, 2016. Crossref, Medline, ISIGoogle Scholar
    • Li, A., J. Wang, D. Zhu, X. Zhang, R. Pan and R. Wang. Arctigenin suppresses transforming growth factor-β1-induced expression of monocyte chemoattractant protein-1 and the subsequent epithelial-mesenchymal transition through reactive oxygen species-dependent ERK/NF-κB signaling pathway in renal tubular epithelial cells. Free Radic. Res. 49: 1095–1113, 2015a. Medline, ISIGoogle Scholar
    • Li, W., S.M. Saud, M.R. Young, G. Chen and B. Hua. Targeting AMPK for cancer prevention and treatment. Oncotarget 6: 7365–7378, 2015b. Crossref, MedlineGoogle Scholar
    • Lin, L., J. Piao, Y. Ma, T. Jin, C. Quan, J. Kong, Y. Li and Z. Lin. Mechanisms underlying cancer growth and apoptosis by DEK overexpression in colorectal cancer. PLoS ONE 9: e111260, 2014. Crossref, Medline, ISIGoogle Scholar
    • Lü, H., Z. Sun, H. Shan and J. Song. Microwave-assisted extraction and purification of arctiin and arctigenin from Fructus Arctii by high-speed countercurrent chromatography. J. Chromatogr. Sci. 54: 472–478, 2016. Medline, ISIGoogle Scholar
    • Morizane, Y., A. Thanos, K. Takeuchi, Y. Murakami, M. Kayama, G. Trichonas, J. Miller, M. Foretz, B. Viollet and D.G. Vavvas. AMP-activated protein kinase suppresses matrix metalloproteinase-9 expression in mouse embryonic fibroblasts. J. Biol. Chem. 286: 16030–16038, 2011. Crossref, Medline, ISIGoogle Scholar
    • Nazemalhosseini, M.E., S.M. Kashfi, H. Mirtalebi, S. Almasi, V. Chaleshi, F.R. Kishani, P. Tarban, M. Molaei, M.R. Zali and J.K. Kuppen. Prognostic significance of nuclear β-catenin expression in patients with colorectal cancer from Iran. Iran. Red Crescent Med. J. 17: e22324, 2015. Medline, ISIGoogle Scholar
    • Ondroušková, E., L. Sommerová and R. Hrstka. Multistep process of establishing carcinoma metastases. Klin. Onkol. 29: 12–17, 2016. Crossref, MedlineGoogle Scholar
    • Park, H., K.H. Song, P.M. Jung, J.E. Kim, H. Ro, M.Y. Kim, J.Y. Ma. Inhibitory effect of arctigenin from Fructus Arctii extract on melanin synthesis via repression of tyrosinase expression. Evid. Based Complement. Alternat. Med. 2013: 965312, 2013. Crossref, MedlineGoogle Scholar
    • Park, K.J., S.B. Cho, Y.L. Park, N. Kim, S.Y. Park, D.S. Myung, W.S. Lee, S.S. Kweon and Y.E. Joo. Prospero homeobox 1 mediates the progression of gastric cancer by inducing tumor cell proliferation and lymphangiogenesis. Gastric Cancer 20: 104–115, 2016. Crossref, Medline, ISIGoogle Scholar
    • Patel, S. Emerging adjuvant therapy for cancer: Propolis and its constituents. J. Diet. Suppl. 13: 245–268, 2016. Crossref, MedlineGoogle Scholar
    • Qi, L.W., Z. Zhang, C.F. Zhang, S. Anderson, Q. Liu, C.S. Yuan and C.Z. Wang. Anti-colon cancer effects of 6-shogaol through G2/M cell cycle arrest by p53/p21-cdc2/cdc25A crosstalk. Am. J. Chin. Med. 43: 743–756, 2015. Link, ISIGoogle Scholar
    • Qin, K, Q. Liu Q, H. Cai H, G. Cao, T. Lu, B. Shen, Y. Shu and B. Cai. Chemical analysis of raw and processed Fructus Arctii by high-performance liquid chromatography/diode array detection-electrospray ionization-mass spectrometry. Pharmacogn. Mag. 10: 541–546, 2014. Google Scholar
    • Ray, P., D. Guha, J. Chakraborty, S. Banerjee, A. Adhikary, S. Chakraborty, T. Das and G. Sa. Crocetin exploits p53-induced death domain (PIDD) and FAS-associated death domain (FADD) proteins to induce apoptosis in colorectal cancer. Sci. Rep. 6: 32979, 2016. Crossref, Medline, ISIGoogle Scholar
    • Sowa, T., T. Menju, M. Sonobe, T. Nakanishi, K. Shikuma, N. Imamura, H. Motoyama, K. Hijiya, A. Aoyama, F. Chen, T. Sato, M. Kobayashi, A. Yoshizawa, H. Haga, T. Sozu and H. Date. Association between epithelial-mesenchymal transition and cancer stemness and their effect on the prognosis of lung adenocarcinoma. Cancer Med. 4: 1853–1862, 2015. Crossref, Medline, ISIGoogle Scholar
    • Tsai, J.H., L.S. Hsu, H.C. Huang, C.L. Lin, M.H. Pan, H.M. Hong and W.J. Chen. 1-(2-Hydroxy-5-methylphenyl)-3-phenyl-1,3-propanedione induces G1 cell cycle arrest and autophagy in HeLa cervical cancer cells. Int. J. Mol. Sci. 17: E1274, 2016. Crossref, Medline, ISIGoogle Scholar
    • Wang, J., C. Chen, S. Wang, Y. Zhang, P. Yin, Z. Gao, J. Xu, D. Feng, Q. Zuo, R. Zhao and T. Chen. Bufalin inhibits HCT116 colon cancer cells and its orthotopic xenograft tumor in mice model through genes related to apoptotic and PTEN/AKT pathways. Gastroenterol. Res. Pract. 2015: 457193, 2015a. Crossref, MedlineGoogle Scholar
    • Wang, Y.H., X.M. Sui, Y.N. Sui, Q.W. Zhu, K. Yan, L.S. Wang, F. Wang and J.H. Zhou. BRD4 induces cell migration and invasion in HCC cells through MMP-2 and MMP-9 activation mediated by the Sonic hedgehog signaling pathway. Oncol. Lett. 10: 2227–2232, 2015b. Crossref, Medline, ISIGoogle Scholar
    • William, W.N., J.S. Kim, D.D. Liu, L. Solis, C. Behrens, J.J. Lee, S.M. Lippman, E.S. Kim, W.K. Hong, I.I. Wistuba and H.Y. Lee. The impact of phosphorylated AMP-activated protein kinase expression on lung cancer survival. Ann. Oncol. 23: 78–85, 2012. Crossref, Medline, ISIGoogle Scholar
    • Xu, Z., X. Wang, M. Zhou, L. Ma, Y. Deng, H. Zhang, A. Zhao, Y. Zhang and W. Jia. The antidiabetic activity of total lignan from Fructus Arctii against alloxan-induced diabetes in mice and rats. Phytother. Res. 22: 97–101, 2008. Crossref, Medline, ISIGoogle Scholar
    • Yakirevich, E., M.B. Resnick, S. Mangray, M. Wheeler, C.L. Jackson, K.A. Lombardo, J. Lee, K.M. Kim, A.J. Gill, K. Wang, K. Gowen, J. Sun, V.A. Miller, P.J. Stephens, S.M. Ali, J.S. Ross, H. Safran. Oncogenic ALK fusion in rare and aggressive subtype of colorectal adenocarcinoma as a potential therapeutic target. Clin. Cancer Res. 22: 3831–3840, 2016. Crossref, Medline, ISIGoogle Scholar
    • Zhang, J., T.T. Guo, L. Yang, Q.S. Du, J. Hua, R.Z. Liu and X. Tang. Effect of arctiin on mouse podocyte epithelial-mesenchymal transition induced by advanced oxidation protein products. Nan Fang Yi Ke Da Xue Xue Bao 32: 379–382, 2012. MedlineGoogle Scholar
    • Zheng, J., Q. Li, W. Wang, Y. Wang, X. Fu, W. Wang, L. Fan and W. Yan. Apoptosis-related protein-1 acts as a tumor suppressor in cholangiocarcinoma cells by inducing cell cycle arrest via downregulation of cyclin-dependent kinase subunits. Oncol. Rep. 35: 809–816, 2016. Crossref, Medline, ISIGoogle Scholar
    Published: 22 August 2017
    Remember to check out the Most Cited Articles!

    Check out our Chinese Medicine Titles today.
    Includes titles by Nobel Winner, Tu You You and more!